Dendrosomal curcumin treatment also led to decreased expression of Lnc-DANCR and EZH2 genes, while upregulating bax, Noxa, PUMA, and p21 genes and downregulating bcl-2 and p53 in the breast cancer cell line. The gene discussed is EZH2; the disease is breast carcinoma.